Achaogen competitorsClear all

Achaogen's top competitors include Protalex, Livzon Pharmaceutical Group and UCB.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Achaogen
Achaogen
Achaogen is a clinical-stage biopharmaceutical company that discovers and develops drugs to treat multi-drug resistant (MDR), gram-negative infections.
Protalex
Protalex
Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
UCB
UCB
UCB is a biopharma company, focusing on neurology and immunology.
Founding Date
Founding Date
2004
Founding Date
1999
Founding Date
1985
Founding Date
1928
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Florham Park, US HQ
Locations
Zhuhai, CN HQ
Chengdu, CN
Qingyuan, CN
Shanghai, CN
Shaoguan, CN
Shenzhen, CN
Zhuhai, CN
Locations
Anderlecht, BE HQ
Malvern, AU
Wien, AT
Braine L'alleud, BE
São Paulo, BR
Sofia, BG
Oakville, CA
see more
Employees
Employees
N/A
Employees
233% decrease
Employees
8,3677% decrease
Employees
8,37110% increase
Valuation ($)
Valuation ($)
1.6 m
Valuation ($)
615.2 k
Valuation ($)
4.6 b
Valuation ($)
23.1 b
Twitter followers
Twitter followers
551
Twitter followers
239
Twitter followers
N/A
Twitter followers
10.6 k
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
463207
Alexa Website Rank
295568
Alexa Website Rank
365218
Employee Rating
Employee Rating
3.7
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
$8.7m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€5.3b (FY, 2020)
Cost of goods
Cost of goods
$31k (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€1.4b (FY, 2020)
Gross profit
Gross profit
$8.7m (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
€4b (FY, 2020)
Net income
Net income
($186.5m) (FY, 2018)
Net income
($5m) (FY, 2018)
Net income
N/A
Net income
€761m (FY, 2020)
For sources of this data, please see the company profile

View company profiles

Protalex
HQ
Florham Park, US
Employees
2↓ 33% decrease

Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.

View company
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
8,367↓ 7% decrease

Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.

View company
UCB
HQ
Anderlecht, BE
Employees
8,371↑ 10% increase

UCB is a biopharma company, focusing on neurology and immunology.

View company